RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination
Introduction: Dyslipidemia-hypertension proves to be a major risk factor for cardiovascular diseases. In order to achieve better adherence and cost-effectiveness than free equivalent combination therapies, a fixed-dose combination therapy with telmisartan (TEL), rosuvastatin calcium (ROS) and amlodi...
Main Authors: | Rujuta P. Mistry, Chainesh Shah, Rakesh Jat |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2022-02-01
|
Series: | Folia Medica |
Subjects: | |
Online Access: | https://foliamedica.bg/article/64339/download/pdf/ |
Similar Items
-
Development and validation of RP HPLC method for determination of metformin and sitagliptin in bulk and pharmaceutical dosage form
by: Kavitha D., et al.
Published: (2017-04-01) -
Stability-indicating RP-HPLC method development and validation for estimation of Mupirocin calcium in bulk and in pharmaceutical formulation
by: Durgeshwari J. Kalal, et al.
Published: (2022-03-01) -
New Validated Stability-Indicating Rp-HPLC Method for Simultaneous
Estimation of Atorvastatin and Ezetimibe in Human Plasma by Using PDA Detector
by: S. Ashutosh Kumar, et al.
Published: (2015-09-01) -
Stability Indicating Liquid Chromatographic Method for the Simultaneous Determination of Rosuvastatin and Ezetimibe in Pharmaceutical Formulations
by: Mathrusri Annapurna Mukthinuthalapati, et al.
Published: (2014-12-01) -
Development and Validation of Bioanalytical Method for Determination of Nebivolol and Valsartan in Human Plasma by Using RP-HPLC
by: Kachave R. N., et al.
Published: (2022-03-01)